ADRB2 and type 1 diabetes mellitus: Most investigators have reported a decreased expression of β-AR by using radioligand binding studies in rodent models of T1DM, but a smaller number of studies did not confirm such changes, and an increased expression has been reported in two studies from one group of investigators [79,80].